-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Structure Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q3 2024.
- Structure Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $92K, a 77.3% decline year-over-year.
- Structure Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$138K, a 138% decline year-over-year.
- Structure Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $236K, a 1288% increase from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)